Skandinaviska Enskilda Banken AB (publ) - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$762,000
+19.4%
101,2310.0%0.01%
+20.0%
Q2 2022$638,000
-24.0%
101,2310.0%0.01%0.0%
Q1 2022$840,000101,2310.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders